Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
12
×
business sponsored company news
american medical association
anaerobic digestion
articles containing video clips
biodegradable waste management
biodegradation
colloids
dosage forms
drug delivery devices
gels
histopathology
illinois
infectious causes of cancer
male genital neoplasia
medical and health professional associations in chicago
neoplastic and hyperplastic prostate disorders
organizations established in 1847
physical chemistry
prostate cancer
rtt
supraorganizations
What
announces
12
×
medical
press
release
technology
12
×
announced
company
protect
augmenix
develops
hydrogels
manufactures
organs
radiotherapy
risk
sells
separate
today
absorbable
proprietary
hydrogel
spaceoar
cancer
prostate
new
patient
treated
american
association
clinical
code
cpt
llc
medicare
patients
platform
positive
spacer
use
used
Language
Current search:
business
×
technology
×
announces
×
@venturebeat.com
6 years ago
KFx Medical, LLC Announces Another and Fourth License of its Knotless Double Row Patents
@venturebeat.com
6 years ago
Medigate Announces $5.35M Seed Round to Protect Connected Medical Devices from Pandemic Cyberattacks Threatening Patient Safety and Privacy
@venturebeat.com
6 years ago
Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018
@venturebeat.com
6 years ago
Augmenix Announces Positive Clinical Trial Results Demonstrating Efficacy of SpaceOAR
@venturebeat.com
6 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com
6 years ago
Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com
6 years ago
TIESRx™ Announces Significant Platform Upgrade
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com
7 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com
7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com
7 years ago
Augmenix Announces New Category 1 CPT® Code from the American Medical Association for Periprostatic Implantation of Biodegradable Material